Correlation Between Pieris Pharmaceuticals and Alzamend Neuro
Can any of the company-specific risk be diversified away by investing in both Pieris Pharmaceuticals and Alzamend Neuro at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Pieris Pharmaceuticals and Alzamend Neuro into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Pieris Pharmaceuticals and Alzamend Neuro, you can compare the effects of market volatilities on Pieris Pharmaceuticals and Alzamend Neuro and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Pieris Pharmaceuticals with a short position of Alzamend Neuro. Check out your portfolio center. Please also check ongoing floating volatility patterns of Pieris Pharmaceuticals and Alzamend Neuro.
Diversification Opportunities for Pieris Pharmaceuticals and Alzamend Neuro
0.65 | Correlation Coefficient |
Poor diversification
The 3 months correlation between Pieris and Alzamend is 0.65. Overlapping area represents the amount of risk that can be diversified away by holding Pieris Pharmaceuticals and Alzamend Neuro in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Alzamend Neuro and Pieris Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Pieris Pharmaceuticals are associated (or correlated) with Alzamend Neuro. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Alzamend Neuro has no effect on the direction of Pieris Pharmaceuticals i.e., Pieris Pharmaceuticals and Alzamend Neuro go up and down completely randomly.
Pair Corralation between Pieris Pharmaceuticals and Alzamend Neuro
Given the investment horizon of 90 days Pieris Pharmaceuticals is expected to generate 0.56 times more return on investment than Alzamend Neuro. However, Pieris Pharmaceuticals is 1.78 times less risky than Alzamend Neuro. It trades about -0.12 of its potential returns per unit of risk. Alzamend Neuro is currently generating about -0.21 per unit of risk. If you would invest 1,725 in Pieris Pharmaceuticals on September 1, 2024 and sell it today you would lose (100.00) from holding Pieris Pharmaceuticals or give up 5.8% of portfolio value over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Significant |
Accuracy | 100.0% |
Values | Daily Returns |
Pieris Pharmaceuticals vs. Alzamend Neuro
Performance |
Timeline |
Pieris Pharmaceuticals |
Alzamend Neuro |
Pieris Pharmaceuticals and Alzamend Neuro Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Pieris Pharmaceuticals and Alzamend Neuro
The main advantage of trading using opposite Pieris Pharmaceuticals and Alzamend Neuro positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Pieris Pharmaceuticals position performs unexpectedly, Alzamend Neuro can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Alzamend Neuro will offset losses from the drop in Alzamend Neuro's long position.Pieris Pharmaceuticals vs. Adaptimmune Therapeutics Plc | Pieris Pharmaceuticals vs. Mereo BioPharma Group | Pieris Pharmaceuticals vs. PDS Biotechnology Corp | Pieris Pharmaceuticals vs. Leap Therapeutics |
Alzamend Neuro vs. Tff Pharmaceuticals | Alzamend Neuro vs. Eliem Therapeutics | Alzamend Neuro vs. Inhibrx | Alzamend Neuro vs. Enliven Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Commodity Channel module to use Commodity Channel Index to analyze current equity momentum.
Other Complementary Tools
Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments |